ARCHIVES

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: James Downing named CEO of St. Jude

June 27, 2014

Information Lacking On Use, Accuracy Of HER2 Tests

September 25, 2009

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 24, 1975

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

April 16, 2004

Generic Drug Makers Set Sights In Taxol Worldwide Market

April 2, 1993

In Brief: President Clinton Appoints Six New Members To The National Cancer Advisory Board

December 11, 1998